New analysis suggests other factors may explain the harms blamed on “ultra-processing.” ...
Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that the first patient has been ...
The FOCUS-2 trial in children complements the recently announced FOCUS-3 trial in adolescents with ADHD NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharm ...
TTI-109 delivered TTI-101-equivalent exposure with improved tolerability and meaningful reductions in disease-relevant STAT3-driven immune cell ...
Some IVF clinics are using AI to perform tasks such as sperm and embryo selection, but some fertility experts question ...
FDA’s PDUFA goal date is November 1, 2026; If approved, mitapivat is positioned to become the first oral PK activator for patients with sickle cell disease; CAMBRIDGE, Mass., Ju ...
The pigments that give these foods their rich red, blue and purple hues belong to a group of plant compounds called anthocyanins, a kind of antioxidant that offers anti-inflammatory benefits.
Reliance on artificial-intelligence tools degrades the abilities of physicians and software engineers, studies show ...
When it comes to cardiovascular health, few supplements have sparked as much public interest — or confusion — as nattokinase.
Holistic hybrid health begins from the inside out. It is nurtured from the outside in with attention to our behavior, ...
Everyday Health on MSN
Staying up even a little too late may lead to weight gain
Depriving yourself of sleep by going to bed even an hour or two later than you should may contribute to weight gain over time ...
Physician groups betraying the public’s trust out of fear of government retaliation has permanent consequences,” writes a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results